A case report of arterial and venous thromboembolism in a patient with severe COVID-19 pneumonia.
Samuel Del CastilloCarlos Minguito CarazoJulio César EcharteMiguel Rodríguez-SantamartaTomás Benito GonzálezSandra Terroba SearaLara Martìnez GonzálezFelipe Fernández-VazquezPublished in: European heart journal. Case reports (2020)
Prothrombotic coagulopathy due to enhanced acute inflammatory response and diffuse intravascular coagulation has been described in severe critical COVID-19 patients. This state of hypercoagulability is associated with organ dysfunction and mortality and may predispose to both, venous and arterial, thromboembolism. Little data are available regarding the best therapeutic and prevention strategies in this scenario, although thrombosis prophylaxis with LMWH has been associated with a better outcome.
Keyphrases
- venous thromboembolism
- inflammatory response
- sars cov
- drug induced
- respiratory failure
- coronavirus disease
- early onset
- liver failure
- pulmonary embolism
- direct oral anticoagulants
- cardiovascular events
- coronary artery
- case report
- oxidative stress
- lipopolysaccharide induced
- electronic health record
- lps induced
- low grade
- risk factors
- toll like receptor
- type diabetes
- intensive care unit
- immune response
- coronary artery disease
- aortic dissection
- deep learning
- artificial intelligence